Clinical Trial

A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer

Name: A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer — clinical trial record (NCT07613567)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study aims to compare the efficacy and safety of "neoadjuvant immunotherapy combined with chemotherapy followed by immunotherapy combined with radiotherapy during the radiotherapy period" versus "standard concurrent chemoradiotherapy" in locally advanced cervical cancer.

Trial Details

NCT Number	NCT07613567
Lead Sponsor	Fujian Cancer Hospital
Conditions	Locally Advanced Cervical Carcinoma
Enrollment	486 participants
Start Date	2026-09-01
Primary Completion	2032-08-31 (estimated)
Study Completion	2032-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-29